| CEL-SCI receives United States patent for use of peptide vaccine technology for autoimmune conditions and allergies.: An article from: BIOTECH Patent News | Digitalby Thomson Gale (Publisher)
| List Price: | $5.95 | | | Available: | Available for download now |
| | Binding: | Digital | | Publisher: | Thomson Gale | | Page Count: | 3 Pages | | Publication Date: | February 01, 2006 |
|
EDITORIAL REVIEWS |
Product Description
This digital document is an article from BIOTECH Patent News, published by Thomson Gale on February 1, 2006. The length of the article is 831 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.Citation DetailsTitle: CEL-SCI receives United States patent for use of peptide vaccine technology for autoimmune conditions and allergies.Publication: BIOTECH Patent News (Newsletter)Date: February 1, 2006Publisher: Thomson GaleVolume: 20 Issue: 2Distributed by Thomson Gale |
|
